Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02875002
Title Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell Lymphomas
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Yale University

B-cell lymphoma

peripheral T-cell lymphoma

mantle cell lymphoma

diffuse large B-cell lymphoma

Burkitt lymphoma


Belinostat + Volasertib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Yale Cancer Center New Haven Connecticut 06511 United States Details
Sidney Kimmel Comprehensive Cancer Baltimore Maryland 21287 United States Details
Massey Cancer Center Richmond Virginia 23298 United States Details
*Shaded cells indicate that there was no data available from for the field